Thurston Springer Miller Herd & Titak’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558K Sell
6,147
-199
-3% -$18.2K 0.2% 132
2026
Q1
$652K Sell
6,346
-1,495
-19% -$169K 0.27% 99
2025
Q4
$982K Buy
7,841
+4,633
+144% +$590K 0.34% 72
2025
Q3
$430K Sell
3,208
-34,608
-92% -$4.54M 0.85% 14
2025
Q2
$5.14M Buy
37,816
+5,327
+16% +$702K 0.66% 29
2025
Q1
$4.31M Buy
32,489
+13,510
+71% +$1.72M 0.72% 26
2024
Q4
$2.15M Buy
18,979
+7,307
+63% +$844K 0.43% 56
2024
Q3
$1.33M Sell
11,672
-2,860
-20% -$314K 0.37% 67
2024
Q2
$1.51M Sell
14,532
-64,572
-82% -$6.85M 0.47% 47
2024
Q1
$8.99M Buy
+79,104
New +$9.07M 3.61% 6

Other funds holding ABT

Thurston Springer Miller Herd & Titak's ABT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak reduced its Abbott (ABT) stake by 3.1% in Q2 2026, selling an estimated $18.2K and leaving 6,147 shares worth $558K. The position accounts for 0.2% of the portfolio, ranked #132.

Thurston Springer Miller Herd & Titak first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.99M in Q1 2024. 1,131 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 6,147 shares of Abbott worth $558K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak sold 199 Abbott shares in Q2 2026, an estimated $18.2K.
  • Abbott made up 0.2% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #132 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • Thurston Springer Miller Herd & Titak's Abbott position peaked at $8.99M in Q1 2024.
  • 1,131 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.